Aytu BioPharma(us:AYTU)

    1.44

    +4.35%

    Updated on 2024-12-23

    Open:1.38
    Close:1.44
    High:1.45
    Low:1.35
    Pre Close:1.38
    Volume:29463.00
    Amount:41485.13
    Turnover:0.48%
    Shares:6.15M
    MarketCap:8.88M
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-03-3128179546532.25%666
    2023-12-3124176928031.78%278
    2023-09-3024172514731.19%357
    2023-06-3024170450330.89%377
    2023-03-313854635614.46%2726
    2022-12-31474026670.64%51221
    2022-09-3055886318014.20%131012
    2022-06-305036195159.38%6916
    dateorgNametotalratiochangeShareschangeRatio
    2024-03-31Nantahala Capital Management, Llc108681219.52%0
    2024-03-31Stonepine Capital Management, Llc4724698.49%0
    2024-03-31Renaissance Technologies Llc713231.28%24003.48%
    2024-03-31Geode Capital Management, Llc345630.62%15174.59%
    2024-03-31Vanguard Group Inc278880.50%6372.34%
    2024-03-31Blackrock Inc.227930.41%0
    2024-03-31Dimensional Fund Advisors Lp152400.27%15240
    2024-03-31Acadian Asset Management Llc146220.26%0
    2024-03-31Northern Trust Corp145640.26%-4-0.03%
    2024-03-31Goldman Sachs Group Inc138820.25%0

    About

    Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.
    Address:7900 East Union Avenue,Suite 920

    Market Movers